ArticlePorcine health management2023
Salmonella enterica subspecies enterica serovar Choleraesuis in a Swedish gilt-producing herd, a case report.
Article in Porcine health management, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed, 2 citations in OpenAlex.
- Establishment of a blocking ELISA using a newly generated monoclonal antibody against Salmonella flagellin for detecting antibodies in infected chickens.BMC veterinary research · 2026Article
- Tackling salmonellosis: A comprehensive exploration of risks factors, impacts, and solutions.Open veterinary journal · 2024Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 3 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundWhen Salmonella enterica subspecies enterica serovar Choleraesuis (S. Choleraesuis) was detected in faecal samples collected within the Swedish Salmonella surveillance program from a gilt multiplying herd in September 2020, S. Choleraesuis had not been detected in domestic pigs or wild boar in Sweden for over 40 years. This report describes the subsequent investigation, identification of possible entry routes and measures undertaken to eliminate the pathogen from the herd. CASE PRESENTATION: In accordance with Swedish regulations, pig movements to and from the farm were restricted, internal biosecurity measures were enhanced, and a test-and-remove strategy was implemented. Testing included repeated faecal sampling, tissue samplings from all dead or euthanized pigs, and serological sampling of replacement gilts. Epidemiological investigations included scrutinising of production records, employee interviews, analysing feed and environmental samples, faecal samples from the herd's purebred gilt supplier, and tissue and faecal samples from wild boars in the adjacent area. Testing of in-contact herds receiving gilts (n = 15) or 30-kg pigs (n = 7) from the multiplier included whole-herd faecal sampling and tissue cultures from pigs that died with signs of septicaemia. In total, S. Choleraesuis was detected in 12/4200 faecal and 5/1350 tissue samples from the herd, and the corresponding groups of pigs were euthanized. All feed and environmental samples as well as samples from the gilt supplier were negative. Testing of contact herds resulted in the identification and culling of one group of S. Choleraesuis-positive gilts. Replacement gilts introduced to the herd from January until May 2021 remained serologically negative during a surveillance-period of five months.
conclusionAlthough speculative, the epidemiological investigation identified indirect transmission from wild boar as possible source of introduction to the herd. Whole-genome sequencing of S. Choleraesuis isolates from wild boar in the area showed that they clustered with isolates from the herd. Repeated testing of the herd indicated that the test-and-remove strategy was successful. In August 2021, all restrictions were removed, and the herd was re-instated as a gilt producing herd. Compensation from the Swedish state to the farmer for production losses, culled animals and extra costs associated with the elimination cost totalled SEK 7 992 234.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.